Clinical trial
A Human Controlled Infection Study to Assess Colonisation and Immunogenicity Following Nasal Inoculation of Malian Adults with Reconstituted Lyophilised Wild Type Neisseria Lactamica (Lactamica Etape 1)
NCT04665791 is registered in ClinicalTrials.gov with Center for Vaccine Development - Mali as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Human Controlled Infection Study to Assess Colonisation and Immunogenicity Following Nasal Inoculation of Malian Adults with Reconstituted Lyophilised Wild Type Neisseria Lactamica (Lactamica Etape 1)
- Lead sponsor
- Center for Vaccine Development - Mali
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 2, 2021
- Completion date
- June 6, 2023
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.